Fibroblasts Are the Primary Contributors to a Disrupted Micro-Environment in End-Stage Pediatric Hypertrophic Cardiomyopathy
Circulation: Genomic and Precision Medicine · 2025
DOI: 10.1161/circgen.125.005192 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation: Genomic and Precision Medicine, 2025. Verfasst von Hanna J Tadros und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Cardiology (H.J.T.), Texas Children's Hospital, Houston. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Fibroblasts. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is a relatively rare but debilitating diagnosis in the pediatric population, and patients with end-stage HCM require heart transplantation. Here, we have examined the transcriptome in ventricular tissue from this patient group to identify cell states and underlying cellular processes unique to pediatric HCM. METHODS: We performed single-nucleus RNA sequencing (snRNA-seq) on explanted hearts at transplant in 3 pediatric patients with end-stage HCM and compared findings to pediatric control and adult HCM. RESULTS: We identified distinct underlying cellular processes in cardiomyocytes, fibroblasts, endothelial cells, and myeloid cells compared with controls. Pediatric HCM was enriched in cardiomyocytes exhibiting stressed myocardium gene signatures and underlying pathways associated with cardiac hypertrophy; cardiac fibroblasts exhibited activation signatures and compared with adult patients, exhibited heightened downstream processes associated with fibrosis and a unique, myofibroblast-like cluster with increased metabolic stress and antiapoptotic properties. We noted depletion of tissue-resident macrophages and increased vascular remodeling in endothelial cells in pediatric HCM. CONCLUSIONS: Our analysis provides the first snRNA-seq analysis focused on end-stage pediatric HCM. Fibroblast-mediated cellular processes were the most prominent in pediatric HCM, which had more downstream processes associated with fibrosis than did adult HCM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pediatric Cardiology (H.J.T.), Texas Children's Hospital, Houston.
- Department of Pediatrics (D.T., H.J.T.), Baylor College of Medicine, Houston, TX.
- Division of Critical Care Medicine (D.T.), Texas Children's Hospital, Houston.
- The Texas Heart Institute at Baylor College of Medicine, Houston (Y.Z., X.L., J.F.M.).
- Department of Integrative Physiology (C.-R.T., J.F.M.), Baylor College of Medicine, Houston, TX.
- Division of Congenital Heart Surgery (I.A.A.), Texas Children's Hospital, Houston.
ORCID-Profile: Hanna J Tadros, Diwakar Turaga, Yi Zhao, Chang-Ru Tsai, Xiao Li, James F Martin
Förderung
- NHLBI NIH HHS
Zitieren
APA
Tadros, H. J., Turaga, D., Zhao, Y., Tsai, C. R., Adachi, I. A., Li, X., & Martin, J. F. (2025). Fibroblasts Are the Primary Contributors to a Disrupted Micro-Environment in End-Stage Pediatric Hypertrophic Cardiomyopathy. Circulation: Genomic and Precision Medicine. https://doi.org/10.1161/circgen.125.005192
Vancouver
Tadros HJ, Turaga D, Zhao Y, Tsai CR, Adachi IA, Li X, et al. Fibroblasts Are the Primary Contributors to a Disrupted Micro-Environment in End-Stage Pediatric Hypertrophic Cardiomyopathy. Circulation: Genomic and Precision Medicine. 2025. doi:10.1161/circgen.125.005192
BibTeX
@article{Tadros2025,
author = {Tadros, Hanna J and Turaga, Diwakar and Zhao, Yi and Tsai, Chang-Ru and Adachi, Iki A and Li, Xiao and Martin, James F},
title = {Fibroblasts Are the Primary Contributors to a Disrupted Micro-Environment in End-Stage Pediatric Hypertrophic Cardiomyopathy},
journal = {Circulation: Genomic and Precision Medicine},
year = {2025},
doi = {10.1161/circgen.125.005192}
}
EUVIMED